The obesity market was valued at USD 16.90 Billion in 2024 driven by the rising obesity rates, sedentary lifestyles, and advancements in innovative therapeutic solutions across the 8 major markets. It is expected to grow at a CAGR of 10.10% during the forecast period of 2025-2034 and attain a market value of USD 44.23 Billion by 2034.
Base Year
Historical Year
Forecast Year
The rising prevalence of obesity, fueled by sedentary lifestyles and poor dietary choices is driving the demand for effective management solutions, boosting market growth.
Key trends in the market include awareness campaigns technological advancements, and innovative therapeutic approaches, encouraging investments in obesity treatment and prevention.
The United States will lead the market due to its advanced healthcare infrastructure, increasing obesity rates, and robust focus on research and development. The region’s strong biopharmaceutical sector and emphasis on innovation further support its market dominance.
Obesity, influenced by sedentary lifestyles and poor dietary habits, significantly increases the risk of chronic diseases such as diabetes and cardiovascular disorders. Rising obesity prevalence worldwide is driving demand for effective management solutions. Key trends include increased awareness campaigns and advancements in digital healthcare and pharmaceutical innovations. These factors are reshaping the market, and encouraging the development of therapies, devices, and technologies to address this growing global health challenge.
Rising Prevalence of Obesity Boost the Market Demand
As per the World Obesity Federation 2023 report, around 51% or over 4.0 billion people globally are anticipated to live with obesity by 2035 (if measures are not taken at the time). This surge in prevalence, driven by sedentary lifestyles and poor dietary choices, is stimulating demand for obesity-related products and services. While wealthier nations often lead in health awareness initiatives, the growing global obesity crisis presents significant opportunities for companies to innovate and expand their offerings in health, nutrition, and wellness sectors.
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by End User
Market Breakup by Region
Market Share by End User to Witness Significant Growth
Based on end users, the market is divided into speciality clinics, hospitals, beauty institutions, and others. Among these, hospitals are expected to dominate the market due to their comprehensive capabilities in addressing obesity through surgical interventions, medical therapies, and multidisciplinary approaches. Obesity-related comorbidities and a growing emphasis on integrated healthcare services are expected to bolster this segment. Additionally, hospitals are poised to drive substantial market growth during the forecast periods, leveraging advanced technologies and specialized care programs to enhance patient outcomes.
Regionally, the market is divided into the United States, United Kingdom, Germany, France, Italy, Spain, Japan and India. Among these, the United States is expected to dominate the market due to its well-established biopharmaceutical sector and several FDA approvals. For instance, in December 2024, the FDA approved Zepbound, a medication developed by Eli Lilly and Company, aimed at chronic weight management for individuals struggling with obesity or those who are overweight with related health issues. Zepbound operates by activating specific hormone receptors in the intestine, which helps to decrease appetite and food intake. Clinical evaluations conducted through two randomized controlled trials demonstrated that Zepbound leads to a statistically significant reduction in body weight, underscoring its effectiveness in promoting healthier weight management. The availability of such key players is likely to elevate market value in the forecast period.
The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Established in 1886 and headquartered in New Jersey, United States, Johnson & Johnson is a global leader in healthcare. The company offers medical devices such as gastric bands, which are used in bariatric surgeries for obesity treatment. These solutions aim to assist individuals in managing obesity effectively by providing innovative and minimally invasive medical technologies.
Now a part of Boston Scientific, Apollo Endosurgery specialises in developing minimally invasive medical devices aimed at advancing therapeutic endoscopy, particularly for managing obesity. Their product portfolio includes the ORBERA® Intragastric Balloon System, a non-surgical weight loss solution, and the OverStitch™ Endoscopic Suturing System, which facilitates a range of less invasive procedures by enabling secure, full-thickness sutures through a flexible endoscope.
Formed in 1923 and headquartered in Denmark, Novo Nordisk A/S focuses on innovative treatments for obesity. Its portfolio includes drugs like Saxenda (liraglutide) and Wegovy (semaglutide), which aid in weight loss and management by regulating appetite. Novo Nordisk is recognized globally for its commitment to addressing obesity and associated health challenges through groundbreaking therapies.
Established in 2012 and headquartered in North Chicago, Illinois, AbbVie is dedicated to advancing metabolic research, including potential treatments for obesity. While specific drugs are under development, AbbVie focuses on innovative therapeutic approaches to tackle obesity-related conditions, reflecting its commitment to improving patient outcomes in the field of metabolic and chronic diseases.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Arena Pharmaceuticals Inc., Atkins Nutritionals, Ltd., Brunswick Corporation, C.H. Boehringer Sohn AG & Ko. KG, EnteroMedics Incorporation, F. Hoffmann-La Roche Ltd, Herbalife Ltd, Orexigen Therapeutics Inc., and NutriSystem Incorporation.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share